All Comments by

  1. Michael G. Agadjanyan on Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis.
  2. David Holtzman on AD Immunotherapy: Toward Prevention, DNA-based Vaccines?
  3. Rachelle Doody on Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
  4. Akihiko Nunomura on Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice.
  5. Russell Swerdlow on Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.
  6. Stephen Staten on Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance.
  7. Paula Moreira on Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.
  8. Jungsu Kim on BACE Inhibitors Hitch Ride into Endosomes via Membrane Anchor
  9. Gjumrakch Aliev on A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
  10. Barbara Calabrese on Plaque Microglia—Mobile But Limited
  11. Jordan Tang on BACE Inhibitors Hitch Ride into Endosomes via Membrane Anchor
  12. Benjamin Wolozin on Trial Troika—Immunotherapy Interrupted, Lipitor Lags, Dimebon Delivers
  13. Michael Parker on Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation.
  14. J. Lucy Boyd on HAI Chicago: PIB in Healthy People
  15. Lary Walker on Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid.